Dragonfly will explore the giant Saturn moon Titan by air, helping scientists learn about the proto-ingredients of life on the satellite's hazy surface.
Dragonfly will fly between sites on Titan’s surface to investigate dune fields and impact sites such as Selk Crater.
Dragonfly integration and testing—the activities involved in assembling the mission's rotorcraft lander and testing it for ...
Abstract: This paper demonstrates the fabrication of a reliable 0.7μm diameter and 5μm deep (0.7x5μm) via-last module, fitting a 1.4μm TSV pitch. Enabling sub-micron TSV diameters requires a thinner ...
Rob Hadick, Dragonfly general partner, joins 'Squawk Box' to discuss the state of crypto, bitcoin price trends, 2026 outlook, future of prediction markets, and more. A military operation Americans ...
Dragonfly Energy (DFLI) announced that it will effect a 1-for-10 reverse stock split of its outstanding common stock. This will be effective for trading purposes as of the commencement of trading on ...
Shares of Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) sank nearly 44% in pre-market trading on Tuesday after the battery technology company announced it will carry out a 1-for-10 reverse stock split ...
(RTTNews) - Dragonfly Energy Holdings Corp. (DFLI), a battery technology company, announced Tuesday that it will implement a 1-for-10 reverse stock split, effective December 18, 2025. Denis Phares, ...
RENO, Nev. - Dragonfly Energy Holdings Corp. (Nasdaq:DFLI), a battery technology company, announced Tuesday it will implement a 1-for-10 reverse stock split effective for trading purposes on Thursday, ...
RENO, Nev., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. ("Dragonfly Energy” or the "Company”) (Nasdaq: DFLI), an industry leader in energy storage and battery technology, today, ...
The five-year-old start-up, which has just 52 employees and is profitable, is now valued at $2.1 billion by investors including Andreessen Horowitz. By Niko Gallogly As an investment banker and ...
AbbVie has scrapped an asset from its ongoing collaboration with Dragonfly Therapeutics, a spokesperson for the Chicago pharma confirmed to Fierce Biotech. “We have terminated clinical activity around ...